Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies (Q81416970)
Jump to navigation
Jump to search
scientific article published on 01 May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies |
scientific article published on 01 May 2005 |
Statements
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies (English)
Noel M Kramer
Eric M Horwitz
Jonathan Cheng
John A Ridge
Steven J Feigenberg
Roger B Cohen
Nicos Nicolaou
Eric J Sherman
James S Babb
Jason A Damsker